Researchers have delved into the intricate heterogeneity of glioblastoma, a notoriously aggressive brain tumor, using advanced single-cell RNA sequencing and innovative zebrafish avatars. Their findings spotlighted the LGALS1 gene’s role in immunosuppression and suggested potential therapeutic avenues for personalized GBM treatment.
Sarepta’s Elevidys secures US label expansion for DMD – Pharmaceutical Technology
Elevidys uses a recombinant adeno-associated virus vector serotype 74 (AAV74) to deliver a dystrophin encoding microdystrophin transgene. Credits: T. Schneider/Shutterstock.com Just a week after Pfizer
June 21, 2024